Angle (AGL)

 

AGL Share PerformanceMore

52 week high80.00 15/06/17
52 week low44.00 30/03/17
52 week change 6.50 (10.40%)
4 week volume5,107,892 29/05/17

Media for (AGL)

Presenter: Andrew Newland, Chief Executive
10/10/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

FTSE lower amid ex-divs ahead of BoE rate call

London shares opened lower as a lengthy list of ex-dividend stocks undoubtedly weighed and as investors looked to the mid...

Parsortix breakthrough in prostate cancer

RNS Number: 1286I Angle PLC 15 June 2017 For immediate release 15 June 2017 ANGLE plc ("the Company") PARSORTIX BREAKTHROUGH DELIVERS RARE BLOOD CELL DISCOVERY IN PROSTATE CANCER Barts Cancer Institute study finds rare type of cell in cancer patient blood linked to survival Use of Parsortix identifies patients that are 10 times m...

Parsortix success reported at ASCO, says ANGLE

ANGLE has announced that researchers have presented successful results from their work using the company's Parsortix ...

Success with Parsortix in Colorectal Cancer

RNS Number: 0859H Angle PLC 05 June 2017 For immediate release 5 June 2017 ANGLE plc ("the Company") SUCCESS WITH PARSORTIX IN COLORECTAL CANCER Clinically relevant results presented at ASCO 2017 cancer conference Demonstrates use of the Parsortix system to predict resistance to cancer drugs ANGLE plc (AIM:AGL OTCQX:ANPCY), the s...

Business Update

RNS Number: 9768D Angle PLC 03 May 2017 For immediate release 3 May 2017 ANGLE plc ("the Company") BUSINESS UPDATE HIGHLIGHTS PROGRESS WITH PARSORTIX LIQUID BIOPSY Ovarian cancer clinical studies progressing well with patient enrolment completed. Headline data on target for reporting this quarter MD Anderson Cancer Center signed...

Holding(s) in Company

RNS Number: 4527B Angle PLC 04 April 2017 For immediate release 4 April 2017 ANGLE plc ("the Company") Holding(s) in Company The Company has been informed by Lombard Odier Investment Managers group ("Lombard") that, following its recent acquisition of Henderson Volantis from Henderson Global plc ("Henderson"), Lombard has acquired ordina...

Parsortix enables analysis in head and neck cancer

RNS Number: 2731B Angle PLC 03 April 2017 For immediate release 3 April 2017 ANGLE plc ("the Company") PARSORTIX ENABLES GENE EXPRESSION ANALYSIS IN HEAD AND NECK CANCER Customer presents clinically relevant results at AACR 2017 with Parsortix where alternative approaches have failed University of Athens, Attikon University H...

Prostate Cancer Update

RNS Number: 9546A Angle PLC 30 March 2017 For immediate release 30 March 2017 ANGLE plc ("the Company") POTENTIAL FOR PREDICTION OF METASTASIS IN PROSTATE CANCER Barts Cancer Institute present new findings at World CDx Europe 2017 conference in London ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is...

Fundamental DataMore

EPS-8.64
Dividend yield0 %

Equity Research (AGL)

edison investment research
ANGLE Plc
16/06/2017
Yesterday Angle announced that researchers from Queen Mary University of London's Barts Cancer Institute (BCI) published new data further supporting Angle’s Parsortix system for use in prostate...
ANGLE Plc
06/06/2017
Toople* (TOOP.L) 3.25p £3.25m The provider of bespoke telecom services to UK SMEs, announced that it received a strong response from investors pursuant to Initial C l o s i n g o f t h e...
ANGLE Plc
04/04/2017
InnovaDerma* (IDP.L) 133.5p £15.81m The UK developer of life sciences, beauty and personal care products today provided an update on trading and announces it has secured new e-tailer distribution...

Latest discussion posts More

  • Tree shake this week???

    Nm
    23-Jun-2017
    millwallfan
  • Telegraph article today

    Whereas the Daily Mail article seemed to relate to the RNS and was very encouraging,; this Telegraph article headed "Blood test could revolutionise prostate cancer treatment" ...
    19-Jun-2017
    investor789
  • Re: Anyone know what's going on ?

    I posted the question the day before the News was announced and after 2 days of strong gains. Now its obvious.
    15-Jun-2017
    Good money after bad

Users' HoldingsMore

Users who hold Angle also hold..
LLOYDS GRP.21%
TESCO20%
GLAXOSMITHKLINE14%
VODAFONE GRP.13%
OPTIBIOTIX H.12%

Codes & Symbols

ISINGB0034330679
SymbolsAGL, LSE:AGL, AGL.L, AGL:LN, LON:AGL, XLON:AGL